Evidence map›Paper›PMID 8947027›Full record

ArticleThe EMBO journal1996

Outline structure of the human L1 cell adhesion molecule and the sites where mutations cause neurological disorders.

A Bateman, M Jouet, J MacFarlane, J S Du, S Kenwrick, C Chothia

Open access · bronzeAbstract read
In one paragraph

Article in The EMBO journal, 1996. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 127 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. L1CAM as an E-selectin Ligand in Colon Cancer.International journal of molecular sciences · 2020
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Neural cell adhesion molecule NrCAM regulates Semaphorin 3F-induced dendritic spine remodeling.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2014
    Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

A BatemanMRC Laboratory of Molecular Biology, Cambridge, UK.
M Jouet
J MacFarlane
J S Du
S Kenwrick
C Chothia
MRC Laboratory of Molecular Biology · GB

Funding

Wellcome Trust
6 · The paper itself

Abstract

The L1 cell adhesion molecule has six domains homologous to members of the immunoglobulin superfamily and five homologous to fibronectin type III domains. We determined the outline structure of the L1 domains by showing that they have, at the key sites that determine conformation, residues similar to those in proteins of known structure. The outline structure describes the relative positions of residues, the major secondary structures and residue solvent accessibility. We use the outline structure to investigate the likely effects of 22 mutations that cause neurological diseases. The mutations are not randomly distributed but cluster in a few regions of the structure. They can be divided into those that act mainly by changing conformation or denaturing their domain and those that alter its surface properties.

Indexed as

Amino Acid SequenceCell Adhesion Molecules, NeuronalDrosophila ProteinsFibronectinsHumansHydrocephalusLeukocyte L1 Antigen ComplexModels, MolecularMolecular Sequence DataMuscle ProteinsMutationMyosin-Light-Chain KinaseNeural Cell Adhesion MoleculesPeptide FragmentsPeptidesProtein ConformationCell Adhesion Molecules, NeuronalDrosophila ProteinsFibronectinsLeukocyte L1 Antigen ComplexMuscle ProteinsMyosin-Light-Chain KinaseNeural Cell Adhesion MoleculesNrg protein, DrosophilaPeptide FragmentsPeptidestelokin

Identifiers

PMID8947027
PMCPMC452426
OpenAlexW81558796

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.